Global Veterinary Infectious Diseases Therapeutics Market Growth 2025-2031
The global Veterinary Infectious Diseases Therapeutics market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Infectious Diseases Therapeutics Industry Forecast” looks at past sales and reviews total world Veterinary Infectious Diseases Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Infectious Diseases Therapeutics sales for 2025 through 2031. With Veterinary Infectious Diseases Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Infectious Diseases Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Infectious Diseases Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Infectious Diseases Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Infectious Diseases Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Infectious Diseases Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Infectious Diseases Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Infectious Diseases Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Veterinary Infectious Diseases Therapeutics market?
What factors are driving Veterinary Infectious Diseases Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Infectious Diseases Therapeutics market opportunities vary by end market size?
How does Veterinary Infectious Diseases Therapeutics break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Veterinary infectious disease is a disease that can be transmitted from one animal to another or from another human being by pathogenic microorganisms.If not treated, will quickly infect animals, animals, will directly result in dairy, food and beverage industry, textile industry future risk, to food service industry, food industry, and families have a negative impact, not only pose a threat to animal veterinary infectious diseases, and pose a threat to humans, their treatment is widely used in veterinary hospital, veterinary clinic, the vet pharmacy, scientific research institutes.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 22%.
LP Information, Inc. (LPI) ' newest research report, the “Veterinary Infectious Diseases Therapeutics Industry Forecast” looks at past sales and reviews total world Veterinary Infectious Diseases Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Veterinary Infectious Diseases Therapeutics sales for 2025 through 2031. With Veterinary Infectious Diseases Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary Infectious Diseases Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Veterinary Infectious Diseases Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary Infectious Diseases Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Veterinary Infectious Diseases Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary Infectious Diseases Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary Infectious Diseases Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary Infectious Diseases Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Antibiotics
- Antiviral
- Antifungal
- Amebicides
- Anthelmintics
- Swine
- Chicken
- Dog
- Cat
- Cow
- Horse
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Elanco Animal Health
- Novartis Animal Health
- Merck
- Pfizer Animal Health
- Sanofi
- Boehringer Ingelheim Vetmedica
- Dechra Animal Health
- Ceva Sante Animale
- Elanco Animal Health
- Virbac
What is the 10-year outlook for the global Veterinary Infectious Diseases Therapeutics market?
What factors are driving Veterinary Infectious Diseases Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary Infectious Diseases Therapeutics market opportunities vary by end market size?
How does Veterinary Infectious Diseases Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Infectious Diseases Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Infectious Diseases Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Infectious Diseases Therapeutics Segment by Type
2.2.1 Antibiotics
2.2.2 Antiviral
2.2.3 Antifungal
2.2.4 Amebicides
2.2.5 Anthelmintics
2.3 Veterinary Infectious Diseases Therapeutics Sales by Type
2.3.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Type (2020-2025)
2.4 Veterinary Infectious Diseases Therapeutics Segment by Application
2.4.1 Swine
2.4.2 Chicken
2.4.3 Dog
2.4.4 Cat
2.4.5 Cow
2.4.6 Horse
2.4.7 Other
2.5 Veterinary Infectious Diseases Therapeutics Sales by Application
2.5.1 Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
3.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Company
3.4 Key Manufacturers Veterinary Infectious Diseases Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Infectious Diseases Therapeutics Product Location Distribution
3.4.2 Players Veterinary Infectious Diseases Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY INFECTIOUS DISEASES THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Infectious Diseases Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Infectious Diseases Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Infectious Diseases Therapeutics Sales Growth
4.4 APAC Veterinary Infectious Diseases Therapeutics Sales Growth
4.5 Europe Veterinary Infectious Diseases Therapeutics Sales Growth
4.6 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Veterinary Infectious Diseases Therapeutics Sales by Country
5.1.1 Americas Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
5.2 Americas Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
5.3 Americas Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Infectious Diseases Therapeutics Sales by Region
6.1.1 APAC Veterinary Infectious Diseases Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Veterinary Infectious Diseases Therapeutics Revenue by Region (2020-2025)
6.2 APAC Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
6.3 APAC Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Infectious Diseases Therapeutics by Country
7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
7.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
7.3 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics by Country
8.1.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Infectious Diseases Therapeutics
10.3 Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
10.4 Industry Chain Structure of Veterinary Infectious Diseases Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Infectious Diseases Therapeutics Distributors
11.3 Veterinary Infectious Diseases Therapeutics Customer
12 WORLD FORECAST REVIEW FOR VETERINARY INFECTIOUS DISEASES THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Veterinary Infectious Diseases Therapeutics Market Size Forecast by Region
12.1.1 Global Veterinary Infectious Diseases Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Infectious Diseases Therapeutics Forecast by Type (2026-2031)
12.7 Global Veterinary Infectious Diseases Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Elanco Animal Health
13.1.1 Elanco Animal Health Company Information
13.1.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Elanco Animal Health Main Business Overview
13.1.5 Elanco Animal Health Latest Developments
13.2 Novartis Animal Health
13.2.1 Novartis Animal Health Company Information
13.2.2 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Animal Health Main Business Overview
13.2.5 Novartis Animal Health Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer Animal Health
13.4.1 Pfizer Animal Health Company Information
13.4.2 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Animal Health Main Business Overview
13.4.5 Pfizer Animal Health Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Boehringer Ingelheim Vetmedica
13.6.1 Boehringer Ingelheim Vetmedica Company Information
13.6.2 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Vetmedica Main Business Overview
13.6.5 Boehringer Ingelheim Vetmedica Latest Developments
13.7 Dechra Animal Health
13.7.1 Dechra Animal Health Company Information
13.7.2 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dechra Animal Health Main Business Overview
13.7.5 Dechra Animal Health Latest Developments
13.8 Ceva Sante Animale
13.8.1 Ceva Sante Animale Company Information
13.8.2 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ceva Sante Animale Main Business Overview
13.8.5 Ceva Sante Animale Latest Developments
13.9 Elanco Animal Health
13.9.1 Elanco Animal Health Company Information
13.9.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Elanco Animal Health Main Business Overview
13.9.5 Elanco Animal Health Latest Developments
13.10 Virbac
13.10.1 Virbac Company Information
13.10.2 Virbac Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Virbac Main Business Overview
13.10.5 Virbac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Veterinary Infectious Diseases Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Veterinary Infectious Diseases Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Veterinary Infectious Diseases Therapeutics Segment by Type
2.2.1 Antibiotics
2.2.2 Antiviral
2.2.3 Antifungal
2.2.4 Amebicides
2.2.5 Anthelmintics
2.3 Veterinary Infectious Diseases Therapeutics Sales by Type
2.3.1 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Type (2020-2025)
2.4 Veterinary Infectious Diseases Therapeutics Segment by Application
2.4.1 Swine
2.4.2 Chicken
2.4.3 Dog
2.4.4 Cat
2.4.5 Cow
2.4.6 Horse
2.4.7 Other
2.5 Veterinary Infectious Diseases Therapeutics Sales by Application
2.5.1 Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Veterinary Infectious Diseases Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Veterinary Infectious Diseases Therapeutics Breakdown Data by Company
3.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Veterinary Infectious Diseases Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Veterinary Infectious Diseases Therapeutics Sale Price by Company
3.4 Key Manufacturers Veterinary Infectious Diseases Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary Infectious Diseases Therapeutics Product Location Distribution
3.4.2 Players Veterinary Infectious Diseases Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VETERINARY INFECTIOUS DISEASES THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Veterinary Infectious Diseases Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Veterinary Infectious Diseases Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Veterinary Infectious Diseases Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Veterinary Infectious Diseases Therapeutics Sales Growth
4.4 APAC Veterinary Infectious Diseases Therapeutics Sales Growth
4.5 Europe Veterinary Infectious Diseases Therapeutics Sales Growth
4.6 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Veterinary Infectious Diseases Therapeutics Sales by Country
5.1.1 Americas Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
5.2 Americas Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
5.3 Americas Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary Infectious Diseases Therapeutics Sales by Region
6.1.1 APAC Veterinary Infectious Diseases Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Veterinary Infectious Diseases Therapeutics Revenue by Region (2020-2025)
6.2 APAC Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
6.3 APAC Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Veterinary Infectious Diseases Therapeutics by Country
7.1.1 Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
7.2 Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
7.3 Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics by Country
8.1.1 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary Infectious Diseases Therapeutics
10.3 Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
10.4 Industry Chain Structure of Veterinary Infectious Diseases Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary Infectious Diseases Therapeutics Distributors
11.3 Veterinary Infectious Diseases Therapeutics Customer
12 WORLD FORECAST REVIEW FOR VETERINARY INFECTIOUS DISEASES THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Veterinary Infectious Diseases Therapeutics Market Size Forecast by Region
12.1.1 Global Veterinary Infectious Diseases Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Veterinary Infectious Diseases Therapeutics Forecast by Type (2026-2031)
12.7 Global Veterinary Infectious Diseases Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Elanco Animal Health
13.1.1 Elanco Animal Health Company Information
13.1.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.1.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Elanco Animal Health Main Business Overview
13.1.5 Elanco Animal Health Latest Developments
13.2 Novartis Animal Health
13.2.1 Novartis Animal Health Company Information
13.2.2 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.2.3 Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Animal Health Main Business Overview
13.2.5 Novartis Animal Health Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.3.3 Merck Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer Animal Health
13.4.1 Pfizer Animal Health Company Information
13.4.2 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.4.3 Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Animal Health Main Business Overview
13.4.5 Pfizer Animal Health Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.5.3 Sanofi Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Boehringer Ingelheim Vetmedica
13.6.1 Boehringer Ingelheim Vetmedica Company Information
13.6.2 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Vetmedica Main Business Overview
13.6.5 Boehringer Ingelheim Vetmedica Latest Developments
13.7 Dechra Animal Health
13.7.1 Dechra Animal Health Company Information
13.7.2 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.7.3 Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Dechra Animal Health Main Business Overview
13.7.5 Dechra Animal Health Latest Developments
13.8 Ceva Sante Animale
13.8.1 Ceva Sante Animale Company Information
13.8.2 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.8.3 Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ceva Sante Animale Main Business Overview
13.8.5 Ceva Sante Animale Latest Developments
13.9 Elanco Animal Health
13.9.1 Elanco Animal Health Company Information
13.9.2 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.9.3 Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Elanco Animal Health Main Business Overview
13.9.5 Elanco Animal Health Latest Developments
13.10 Virbac
13.10.1 Virbac Company Information
13.10.2 Virbac Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
13.10.3 Virbac Veterinary Infectious Diseases Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Virbac Main Business Overview
13.10.5 Virbac Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Veterinary Infectious Diseases Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Infectious Diseases Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Major Players of Amebicides
Table 7. Major Players of Anthelmintics
Table 8. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 9. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Table 10. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 11. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2020-2025)
Table 12. Global Veterinary Infectious Diseases Therapeutics Sale Price by Type (2020-2025) & (USD/KG)
Table 13. Global Veterinary Infectious Diseases Therapeutics Sale by Application (2020-2025) & (KG)
Table 14. Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2020-2025)
Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2020-2025)
Table 17. Global Veterinary Infectious Diseases Therapeutics Sale Price by Application (2020-2025) & (USD/KG)
Table 18. Global Veterinary Infectious Diseases Therapeutics Sales by Company (2020-2025) & (KG)
Table 19. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2020-2025)
Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company (2020-2025)
Table 22. Global Veterinary Infectious Diseases Therapeutics Sale Price by Company (2020-2025) & (USD/KG)
Table 23. Key Manufacturers Veterinary Infectious Diseases Therapeutics Producing Area Distribution and Sales Area
Table 24. Players Veterinary Infectious Diseases Therapeutics Products Offered
Table 25. Veterinary Infectious Diseases Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Veterinary Infectious Diseases Therapeutics Sales by Geographic Region (2020-2025) & (KG)
Table 29. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Veterinary Infectious Diseases Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Veterinary Infectious Diseases Therapeutics Sales by Country/Region (2020-2025) & (KG)
Table 33. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 37. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2020-2025)
Table 38. Americas Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 40. Americas Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 41. APAC Veterinary Infectious Diseases Therapeutics Sales by Region (2020-2025) & (KG)
Table 42. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2020-2025)
Table 43. APAC Veterinary Infectious Diseases Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 45. APAC Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 46. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 47. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 49. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 50. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 51. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 53. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 54. Key Market Drivers & Growth Opportunities of Veterinary Infectious Diseases Therapeutics
Table 55. Key Market Challenges & Risks of Veterinary Infectious Diseases Therapeutics
Table 56. Key Industry Trends of Veterinary Infectious Diseases Therapeutics
Table 57. Veterinary Infectious Diseases Therapeutics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Veterinary Infectious Diseases Therapeutics Distributors List
Table 60. Veterinary Infectious Diseases Therapeutics Customer List
Table 61. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Region (2026-2031) & (KG)
Table 62. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 64. Americas Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Veterinary Infectious Diseases Therapeutics Sales Forecast by Region (2026-2031) & (KG)
Table 66. APAC Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 68. Europe Veterinary Infectious Diseases Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 70. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type (2026-2031) & (KG)
Table 72. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application (2026-2031) & (KG)
Table 74. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Elanco Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 76. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 77. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 78. Elanco Animal Health Main Business
Table 79. Elanco Animal Health Latest Developments
Table 80. Novartis Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 82. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Animal Health Main Business
Table 84. Novartis Animal Health Latest Developments
Table 85. Merck Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 87. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Pfizer Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 92. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Animal Health Main Business
Table 94. Pfizer Animal Health Latest Developments
Table 95. Sanofi Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 97. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Boehringer Ingelheim Vetmedica Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 102. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Vetmedica Main Business
Table 104. Boehringer Ingelheim Vetmedica Latest Developments
Table 105. Dechra Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 107. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Dechra Animal Health Main Business
Table 109. Dechra Animal Health Latest Developments
Table 110. Ceva Sante Animale Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 112. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Ceva Sante Animale Main Business
Table 114. Ceva Sante Animale Latest Developments
Table 115. Elanco Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 117. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Elanco Animal Health Main Business
Table 119. Elanco Animal Health Latest Developments
Table 120. Virbac Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. Virbac Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 122. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Virbac Main Business
Table 124. Virbac Latest Developments
Table 1. Veterinary Infectious Diseases Therapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Veterinary Infectious Diseases Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Antiviral
Table 5. Major Players of Antifungal
Table 6. Major Players of Amebicides
Table 7. Major Players of Anthelmintics
Table 8. Global Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 9. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Table 10. Global Veterinary Infectious Diseases Therapeutics Revenue by Type (2020-2025) & ($ million)
Table 11. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2020-2025)
Table 12. Global Veterinary Infectious Diseases Therapeutics Sale Price by Type (2020-2025) & (USD/KG)
Table 13. Global Veterinary Infectious Diseases Therapeutics Sale by Application (2020-2025) & (KG)
Table 14. Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2020-2025)
Table 15. Global Veterinary Infectious Diseases Therapeutics Revenue by Application (2020-2025) & ($ million)
Table 16. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application (2020-2025)
Table 17. Global Veterinary Infectious Diseases Therapeutics Sale Price by Application (2020-2025) & (USD/KG)
Table 18. Global Veterinary Infectious Diseases Therapeutics Sales by Company (2020-2025) & (KG)
Table 19. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company (2020-2025)
Table 20. Global Veterinary Infectious Diseases Therapeutics Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company (2020-2025)
Table 22. Global Veterinary Infectious Diseases Therapeutics Sale Price by Company (2020-2025) & (USD/KG)
Table 23. Key Manufacturers Veterinary Infectious Diseases Therapeutics Producing Area Distribution and Sales Area
Table 24. Players Veterinary Infectious Diseases Therapeutics Products Offered
Table 25. Veterinary Infectious Diseases Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Veterinary Infectious Diseases Therapeutics Sales by Geographic Region (2020-2025) & (KG)
Table 29. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Geographic Region (2020-2025)
Table 30. Global Veterinary Infectious Diseases Therapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Veterinary Infectious Diseases Therapeutics Sales by Country/Region (2020-2025) & (KG)
Table 33. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2020-2025)
Table 34. Global Veterinary Infectious Diseases Therapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 37. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2020-2025)
Table 38. Americas Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 40. Americas Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 41. APAC Veterinary Infectious Diseases Therapeutics Sales by Region (2020-2025) & (KG)
Table 42. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Region (2020-2025)
Table 43. APAC Veterinary Infectious Diseases Therapeutics Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 45. APAC Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 46. Europe Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 47. Europe Veterinary Infectious Diseases Therapeutics Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 49. Europe Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 50. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Country (2020-2025) & (KG)
Table 51. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Type (2020-2025) & (KG)
Table 53. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales by Application (2020-2025) & (KG)
Table 54. Key Market Drivers & Growth Opportunities of Veterinary Infectious Diseases Therapeutics
Table 55. Key Market Challenges & Risks of Veterinary Infectious Diseases Therapeutics
Table 56. Key Industry Trends of Veterinary Infectious Diseases Therapeutics
Table 57. Veterinary Infectious Diseases Therapeutics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Veterinary Infectious Diseases Therapeutics Distributors List
Table 60. Veterinary Infectious Diseases Therapeutics Customer List
Table 61. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Region (2026-2031) & (KG)
Table 62. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Region (2026-2031) & ($ millions)
Table 63. Americas Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 64. Americas Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 65. APAC Veterinary Infectious Diseases Therapeutics Sales Forecast by Region (2026-2031) & (KG)
Table 66. APAC Veterinary Infectious Diseases Therapeutics Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 67. Europe Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 68. Europe Veterinary Infectious Diseases Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Forecast by Country (2026-2031) & (KG)
Table 70. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue Forecast by Country (2026-2031) & ($ millions)
Table 71. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Type (2026-2031) & (KG)
Table 72. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Type (2026-2031) & ($ millions)
Table 73. Global Veterinary Infectious Diseases Therapeutics Sales Forecast by Application (2026-2031) & (KG)
Table 74. Global Veterinary Infectious Diseases Therapeutics Revenue Forecast by Application (2026-2031) & ($ millions)
Table 75. Elanco Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 76. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 77. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 78. Elanco Animal Health Main Business
Table 79. Elanco Animal Health Latest Developments
Table 80. Novartis Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 82. Novartis Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Novartis Animal Health Main Business
Table 84. Novartis Animal Health Latest Developments
Table 85. Merck Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 87. Merck Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Pfizer Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 92. Pfizer Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Pfizer Animal Health Main Business
Table 94. Pfizer Animal Health Latest Developments
Table 95. Sanofi Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. Sanofi Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 97. Sanofi Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Sanofi Main Business
Table 99. Sanofi Latest Developments
Table 100. Boehringer Ingelheim Vetmedica Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 102. Boehringer Ingelheim Vetmedica Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Boehringer Ingelheim Vetmedica Main Business
Table 104. Boehringer Ingelheim Vetmedica Latest Developments
Table 105. Dechra Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 107. Dechra Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Dechra Animal Health Main Business
Table 109. Dechra Animal Health Latest Developments
Table 110. Ceva Sante Animale Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 112. Ceva Sante Animale Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Ceva Sante Animale Main Business
Table 114. Ceva Sante Animale Latest Developments
Table 115. Elanco Animal Health Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 117. Elanco Animal Health Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Elanco Animal Health Main Business
Table 119. Elanco Animal Health Latest Developments
Table 120. Virbac Basic Information, Veterinary Infectious Diseases Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 121. Virbac Veterinary Infectious Diseases Therapeutics Product Portfolios and Specifications
Table 122. Virbac Veterinary Infectious Diseases Therapeutics Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Virbac Main Business
Table 124. Virbac Latest Developments
LIST OF FIGURES
Figure 1. Picture of Veterinary Infectious Diseases Therapeutics
Figure 2. Veterinary Infectious Diseases Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Infectious Diseases Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Antiviral
Figure 13. Product Picture of Antifungal
Figure 14. Product Picture of Amebicides
Figure 15. Product Picture of Anthelmintics
Figure 16. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2025
Figure 17. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2020-2025)
Figure 18. Veterinary Infectious Diseases Therapeutics Consumed in Swine
Figure 19. Global Veterinary Infectious Diseases Therapeutics Market: Swine (2020-2025) & (KG)
Figure 20. Veterinary Infectious Diseases Therapeutics Consumed in Chicken
Figure 21. Global Veterinary Infectious Diseases Therapeutics Market: Chicken (2020-2025) & (KG)
Figure 22. Veterinary Infectious Diseases Therapeutics Consumed in Dog
Figure 23. Global Veterinary Infectious Diseases Therapeutics Market: Dog (2020-2025) & (KG)
Figure 24. Veterinary Infectious Diseases Therapeutics Consumed in Cat
Figure 25. Global Veterinary Infectious Diseases Therapeutics Market: Cat (2020-2025) & (KG)
Figure 26. Veterinary Infectious Diseases Therapeutics Consumed in Cow
Figure 27. Global Veterinary Infectious Diseases Therapeutics Market: Cow (2020-2025) & (KG)
Figure 28. Veterinary Infectious Diseases Therapeutics Consumed in Horse
Figure 29. Global Veterinary Infectious Diseases Therapeutics Market: Horse (2020-2025) & (KG)
Figure 30. Veterinary Infectious Diseases Therapeutics Consumed in Other
Figure 31. Global Veterinary Infectious Diseases Therapeutics Market: Other (2020-2025) & (KG)
Figure 32. Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2024)
Figure 33. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application in 2025
Figure 34. Veterinary Infectious Diseases Therapeutics Sales by Company in 2025 (KG)
Figure 35. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2025
Figure 36. Veterinary Infectious Diseases Therapeutics Revenue by Company in 2025 ($ millions)
Figure 37. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company in 2025
Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 41. Americas Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 42. APAC Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 43. APAC Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 44. Europe Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 45. Europe Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 46. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 47. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 48. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Country in 2025
Figure 49. Americas Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Figure 50. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 51. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 52. United States Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Canada Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Mexico Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. Brazil Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Region in 2025
Figure 57. APAC Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2020-2025)
Figure 58. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 59. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 60. China Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 61. Japan Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62. South Korea Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. India Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. Australia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. China Taiwan Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Country in 2025
Figure 68. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Figure 69. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 70. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 71. Germany Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. France Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. UK Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Italy Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Russia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2020-2025)
Figure 77. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 78. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 79. Egypt Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 80. South Africa Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 81. Israel Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 82. Turkey Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 83. GCC Countries Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Veterinary Infectious Diseases Therapeutics in 2025
Figure 85. Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
Figure 86. Industry Chain Structure of Veterinary Infectious Diseases Therapeutics
Figure 87. Channels of Distribution
Figure 88. Global Veterinary Infectious Diseases Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 89. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 90. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 91. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 92. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 93. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Veterinary Infectious Diseases Therapeutics
Figure 2. Veterinary Infectious Diseases Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Veterinary Infectious Diseases Therapeutics Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Veterinary Infectious Diseases Therapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Veterinary Infectious Diseases Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2024)
Figure 10. Veterinary Infectious Diseases Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Antibiotics
Figure 12. Product Picture of Antiviral
Figure 13. Product Picture of Antifungal
Figure 14. Product Picture of Amebicides
Figure 15. Product Picture of Anthelmintics
Figure 16. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Type in 2025
Figure 17. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Type (2020-2025)
Figure 18. Veterinary Infectious Diseases Therapeutics Consumed in Swine
Figure 19. Global Veterinary Infectious Diseases Therapeutics Market: Swine (2020-2025) & (KG)
Figure 20. Veterinary Infectious Diseases Therapeutics Consumed in Chicken
Figure 21. Global Veterinary Infectious Diseases Therapeutics Market: Chicken (2020-2025) & (KG)
Figure 22. Veterinary Infectious Diseases Therapeutics Consumed in Dog
Figure 23. Global Veterinary Infectious Diseases Therapeutics Market: Dog (2020-2025) & (KG)
Figure 24. Veterinary Infectious Diseases Therapeutics Consumed in Cat
Figure 25. Global Veterinary Infectious Diseases Therapeutics Market: Cat (2020-2025) & (KG)
Figure 26. Veterinary Infectious Diseases Therapeutics Consumed in Cow
Figure 27. Global Veterinary Infectious Diseases Therapeutics Market: Cow (2020-2025) & (KG)
Figure 28. Veterinary Infectious Diseases Therapeutics Consumed in Horse
Figure 29. Global Veterinary Infectious Diseases Therapeutics Market: Horse (2020-2025) & (KG)
Figure 30. Veterinary Infectious Diseases Therapeutics Consumed in Other
Figure 31. Global Veterinary Infectious Diseases Therapeutics Market: Other (2020-2025) & (KG)
Figure 32. Global Veterinary Infectious Diseases Therapeutics Sale Market Share by Application (2024)
Figure 33. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Application in 2025
Figure 34. Veterinary Infectious Diseases Therapeutics Sales by Company in 2025 (KG)
Figure 35. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Company in 2025
Figure 36. Veterinary Infectious Diseases Therapeutics Revenue by Company in 2025 ($ millions)
Figure 37. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Company in 2025
Figure 38. Global Veterinary Infectious Diseases Therapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 39. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share by Geographic Region in 2025
Figure 40. Americas Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 41. Americas Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 42. APAC Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 43. APAC Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 44. Europe Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 45. Europe Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 46. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales 2020-2025 (KG)
Figure 47. Middle East & Africa Veterinary Infectious Diseases Therapeutics Revenue 2020-2025 ($ millions)
Figure 48. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Country in 2025
Figure 49. Americas Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Figure 50. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 51. Americas Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 52. United States Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Canada Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. Mexico Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. Brazil Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Region in 2025
Figure 57. APAC Veterinary Infectious Diseases Therapeutics Revenue Market Share by Region (2020-2025)
Figure 58. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 59. APAC Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 60. China Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 61. Japan Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62. South Korea Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. Southeast Asia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. India Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. Australia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. China Taiwan Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 67. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Country in 2025
Figure 68. Europe Veterinary Infectious Diseases Therapeutics Revenue Market Share by Country (2020-2025)
Figure 69. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 70. Europe Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 71. Germany Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72. France Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. UK Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Italy Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 75. Russia Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 76. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Country (2020-2025)
Figure 77. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Type (2020-2025)
Figure 78. Middle East & Africa Veterinary Infectious Diseases Therapeutics Sales Market Share by Application (2020-2025)
Figure 79. Egypt Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 80. South Africa Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 81. Israel Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 82. Turkey Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 83. GCC Countries Veterinary Infectious Diseases Therapeutics Revenue Growth 2020-2025 ($ millions)
Figure 84. Manufacturing Cost Structure Analysis of Veterinary Infectious Diseases Therapeutics in 2025
Figure 85. Manufacturing Process Analysis of Veterinary Infectious Diseases Therapeutics
Figure 86. Industry Chain Structure of Veterinary Infectious Diseases Therapeutics
Figure 87. Channels of Distribution
Figure 88. Global Veterinary Infectious Diseases Therapeutics Sales Market Forecast by Region (2026-2031)
Figure 89. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Region (2026-2031)
Figure 90. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Type (2026-2031)
Figure 91. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Type (2026-2031)
Figure 92. Global Veterinary Infectious Diseases Therapeutics Sales Market Share Forecast by Application (2026-2031)
Figure 93. Global Veterinary Infectious Diseases Therapeutics Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
135 pages
Global Livestock External Parasiticide Market Growth 2025-2031
US$ 3,660.00
December 2025
88 pages
Global Relationship DNA Tests Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
March 2024
149 pages
